Switch to:

Aerie Pharmaceuticals Cash-to-Debt

: 5.84 (As of Jun. 2019)
View and export this data going back to 2013. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Aerie Pharmaceuticals's cash to debt ratio for the quarter that ended in Jun. 2019 was 5.84.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Aerie Pharmaceuticals could pay off its debt using the cash in hand for the quarter that ended in Jun. 2019.

NAS:AERI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.26   Max: No Debt
Current: 5.84

0.26
No Debt

During the past 8 years, Aerie Pharmaceuticals's highest Cash to Debt Ratio was No Debt. The lowest was 0.26. And the median was 2.02.

NAS:AERI's Cash-to-Debt is ranked higher than
67% of the 927 Companies
in the Drug Manufacturers industry.

( Industry Median: 1.17 vs. NAS:AERI: 5.84 )

Aerie Pharmaceuticals Cash-to-Debt Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Aerie Pharmaceuticals Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Cash-to-Debt Premium Member Only Premium Member Only Premium Member Only 1.14 1.11 1.89 2.02 No Debt

Aerie Pharmaceuticals Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Cash-to-Debt Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.31 No Debt No Debt 8.72 5.84

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Aerie Pharmaceuticals Cash-to-Debt Distribution

* The bar in red indicates where Aerie Pharmaceuticals's Cash-to-Debt falls into.



Aerie Pharmaceuticals Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Aerie Pharmaceuticals's Cash to Debt Ratio for the fiscal year that ended in Dec. 2018 is calculated as:

Aerie Pharmaceuticals had no debt.

Aerie Pharmaceuticals's Cash to Debt Ratio for the quarter that ended in Jun. 2019 is calculated as:

Aerie Pharmaceuticals had no debt.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Aerie Pharmaceuticals  (NAS:AERI) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Aerie Pharmaceuticals Cash-to-Debt Related Terms


Aerie Pharmaceuticals Cash-to-Debt Headlines

From the Internet

Is Aerie Pharmaceuticals a Buy?

- Fool 2019-10-21 09:20:00

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)